Malin-backed Altan sets sights on the US with painkiller drug

Malin-backed Altan sets sights on the US with painkiller drug

Irish biotech investor Malin Corporation owns around two-thirds of drug company; Malin’s chief business officer says only one other intravenous paracetamol currently available in US market, giving parent firm a potential exit

Altan, a drug company backed by Irish biotech investor Malin Corporation, is poised to enter the US market potentially providing its owner with an exit.

Irish stock exchange listed Malin owns about two-thirds of Altan, which last week announced it was seeking to have its intravenous paracetamol approved by US regulators. Malin’s chief business and financial officer Darragh Lyons said there was only one other IV paracetamol currently available in the US and Altan should...

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post